Viglianti Gregory A, Planelles Vicente, Hanley Timothy M
Department of Microbiology, Boston University School of Medicine, Boston, MA 02118.
Department of Pathology, University of Utah Health, Salt Lake City, UT 84105.
J Virol. 2021 Mar 10;95(7). doi: 10.1128/JVI.02141-20. Epub 2021 Jan 20.
Macrophages are infected by HIV-1 and contribute to both viral spread and pathogenesis. Recent human and animal studies suggest that HIV-1-infected macrophages serve as a reservoir that contributes to HIV-1 persistence during anti-retroviral therapy. The ability of macrophages to serve as persistent viral reservoirs is likely influenced by the local tissue microenvironment, including interactions with pathogenic and commensal microbes. Here we show that the sexually transmitted pathogen (GC) and the gut-associated microbe (), which encode ligands for both Toll-like receptor 2 (TLR2) and TLR4, repressed HIV-1 replication in macrophages and thereby induced a state reminiscent of viral latency. This repression was mediated by signaling through TLR4 and the adaptor protein TRIF and was associated with increased production of type I interferons. Inhibiting TLR4 signaling, blocking type 1 interferon, or knocking-down TRIF reversed LPS- and GC-mediated repression of HIV-1. Finally, the repression of HIV-1 in macrophages was associated with the recruitment of interferon regulatory factor 8 (IRF8) to the interferon stimulated response element (ISRE) downstream of the 5' HIV-1 long terminal repeat (LTR). Our data indicate that IRF8 is responsible for repression of HIV-1 replication in macrophages in response to TRIF-dependent signaling during GC and co-infection. These findings highlight the potential role of macrophages as HIV-1 reservoirs as well as the role of the tissue microenvironment and co-infections as modulators of HIV-1 persistence. The major barrier toward the eradication of HIV-1 infection is the presence of a small reservoir of latently infected cells, which include CD4+ T cells and macrophages that escape immune-mediated clearance and the effects of anti-retroviral therapy. There remain crucial gaps in our understanding of the molecular mechanisms that lead to transcriptionally silent or latent HIV-1 infection of macrophages. The significance of our research is in identifying microenvironmental factors, such as commensal and pathogenic microbes, that can contribute to the establishment and maintenance of latent HIV-1 infection in macrophages. It is hoped that identifying key processes contributing to HIV-1 persistence in macrophages may ultimately lead to novel therapeutics to eliminate latent HIV-1 reservoirs .
巨噬细胞会被HIV-1感染,并在病毒传播和发病机制中发挥作用。最近的人体和动物研究表明,被HIV-1感染的巨噬细胞可作为一种储存库,在抗逆转录病毒治疗期间促成HIV-1的持续存在。巨噬细胞作为持续性病毒储存库的能力可能受局部组织微环境的影响,包括与致病微生物和共生微生物的相互作用。在此,我们表明,性传播病原体(淋球菌)和肠道相关微生物(未提及具体名称)编码Toll样受体2(TLR2)和TLR4的配体,它们可抑制巨噬细胞中的HIV-1复制,从而诱导出一种类似于病毒潜伏的状态。这种抑制作用是通过TLR4和衔接蛋白TRIF的信号传导介导的,并且与I型干扰素的产生增加有关。抑制TLR4信号传导、阻断I型干扰素或敲低TRIF可逆转LPS和淋球菌介导的HIV-1抑制作用。最后,巨噬细胞中HIV-1的抑制作用与干扰素调节因子8(IRF8)募集到5' HIV-1长末端重复序列(LTR)下游的干扰素刺激反应元件(ISRE)有关。我们的数据表明,在淋球菌和(未提及的微生物)共同感染期间,IRF8负责响应TRIF依赖性信号传导而抑制巨噬细胞中的HIV-1复制。这些发现突出了巨噬细胞作为HIV-1储存库的潜在作用,以及组织微环境和共同感染作为HIV-1持续性调节因子的作用。根除HIV-1感染的主要障碍是存在一小部分潜伏感染细胞的储存库,其中包括逃避免疫介导清除和抗逆转录病毒治疗影响的CD4+ T细胞和巨噬细胞。我们对导致巨噬细胞转录沉默或潜伏性HIV-1感染的分子机制的理解仍存在关键差距。我们研究的意义在于识别微环境因素,如共生和致病微生物,它们可促成巨噬细胞中潜伏性HIV-1感染的建立和维持。希望识别出促成HIV-1在巨噬细胞中持续存在的关键过程最终可能会带来消除潜伏性HIV-1储存库的新型疗法。